跳至主要内容
临床试验/NCT01557296
NCT01557296已完成2 期

Comparing Treatment With Food of Small Particle Size and Food of Large Particle Size in Subjects With Diabetic Gastroparesis. Evaluation of Diagnostic Methods. Determination of the Motility of Gastric Emptying After Intervention

Göteborg University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2007年9月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
Metabolic Control - HbA1c

研究概览

简要总结

The objective of the study is in subjects with Insulin Treated Diabetes Mellitus type 1 or 2 and gastroparesis:

  • validate radiopaque markers with fluoroscopy with gastric scintigraphy method
  • study the difference of metabolic control including the frequents of hypoglycaemia, gastrointestinal symptoms, quality of life and nutrition state during dietary treatment of food of small particle size compared with food of large particle size
  • validate the radiopaque markers method and measurement of the blood glucose and gastrointestinal symptoms after a test meal, against the gastric scintigraphy
  • determine if the function of gastric emptying can be improved after intervention

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •diabetes type 1 or 2 and gastroparesis
  • •must be able to understand oral and verbal instructions

排除标准

  • •gastrointestinal surgery
  • •other gastrointestinal disease
  • •S-Creatinine >150 umol/L
  • •mental disease
  • •cerebral disease
  • •collagen disease
  • •untreated endocrine disease
  • •anticholinergic drugs
  • •psychopharmacologic drugs
  • •addiction to drugs as alcohol and narcotics
  • •vegetarian

研究组 & 干预措施

Diabetic diet

Placebo Comparator

Control group. Subjects with Insulin Treated Diabetes Mellitus and Gastroparesis. Diet: Food of large particle size during 20 weeks.

干预措施: dietary treatment: food of small particle size (Dietary Supplement)

Diabetic diet

Placebo Comparator

Control group. Subjects with Insulin Treated Diabetes Mellitus and Gastroparesis. Diet: Food of large particle size during 20 weeks.

干预措施: Validate X-ray diagnostic method. (Radiation)

Diabetic diet

Placebo Comparator

Control group. Subjects with Insulin Treated Diabetes Mellitus and Gastroparesis. Diet: Food of large particle size during 20 weeks.

干预措施: Can the motility be improved (Other)

Diabetic diet

Placebo Comparator

Control group. Subjects with Insulin Treated Diabetes Mellitus and Gastroparesis. Diet: Food of large particle size during 20 weeks.

干预措施: postprandial plasma glucose (Biological)

Diet food in small particle size

Active Comparator

Intervention group: Subjects with Insulin Treated Diabetes and Gastroparesis. Intervention Diet: Food of small particle size during 20 weeks.

干预措施: dietary treatment: food of small particle size (Dietary Supplement)

Diet food in small particle size

Active Comparator

Intervention group: Subjects with Insulin Treated Diabetes and Gastroparesis. Intervention Diet: Food of small particle size during 20 weeks.

干预措施: Validate X-ray diagnostic method. (Radiation)

Diet food in small particle size

Active Comparator

Intervention group: Subjects with Insulin Treated Diabetes and Gastroparesis. Intervention Diet: Food of small particle size during 20 weeks.

干预措施: Can the motility be improved (Other)

Diet food in small particle size

Active Comparator

Intervention group: Subjects with Insulin Treated Diabetes and Gastroparesis. Intervention Diet: Food of small particle size during 20 weeks.

干预措施: postprandial plasma glucose (Biological)

结局指标

主要结局

Metabolic Control - HbA1c

时间窗: 22 weeks

次要结局

  • gastrointestinal symptoms - Questionnaire: Patient Assessment of upper Gastrointestinal Disorders Symptoms, Gastrointestinal Symptom Rating Scale(22 weeks)

研究者

发起方
Göteborg University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验